Asthma Reduction with Inhaled corticoSteroids in Children with a high risk for the development of asthma (At RISC).

CAPHRI, The Research Institute of the University Maastricht0 sites97 target enrollmentTBD

Conditionsasthma

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: asthma
Sponsor: CAPHRI, The Research Institute of the University Maastricht
Enrollment: 97
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Investigators

Sponsor

CAPHRI, The Research Institute of the University Maastricht

Eligibility Criteria

Inclusion Criteria

•1\. Male and female patients aged 1\-4,5 years with a familial predisposition for asthma in the first degree, who have experienced at least 2 separate periods with wheeze lasting at least 2 days each documented by their general practitioner;
•2\. And for each patient, who enters the study a written informed consent by the parent or guardian of the patient should be obtained.

Exclusion Criteria

•1\. Patients, who have been treated with pulmonary anti\-inflammatory inhaled drugs during more than 2 weeks or anti\-inflammatory oral drugs during more than 1 week preceding the study. Patients, who have been hospitalised for asthma in the 2 weeks prior to the study;
•2\. Patients, who have serious respiratory morbidity (e.g. broncho\-pulmonary dysplasia, cystic fibrosis, tuberculosis);

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Not Applicable

Asthma Reduction with Inhaled corticoSteroids in Children with a high risk for the development of asthma (At RISC)

ISRCTN58244066Care and Public Health Research Institute (CAPHRI), University Maastricht (Netherlands)97

Completed

Phase 3

Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)Asthma

NCT00495157Milton S. Hershey Medical Center342

Recruiting

Phase 4

Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced WheezingAsthmaInflammation

NCT03889743St. Olavs Hospital280

Completed

Not Applicable

An online study to change perceptions of asthma and asthma medication in adults

ISRCTN70438411niversity College London891

Terminated

Not Applicable

Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?Adrenal Insufficiency

NCT00560625HaEmek Medical Center, Israel50